Predictors of Posttransplant Lymphoproliferative Disease in Pediatric Patients
- PMID: 39887368
- DOI: 10.1002/lary.32024
Predictors of Posttransplant Lymphoproliferative Disease in Pediatric Patients
Abstract
Objective: Posttransplant lymphoproliferative disorder (PTLD) is a complication of pediatric solid organ transplantation. Benign adenotonsillar lymphoid hyperplasia confounds the ability to diagnose PTLD. Our aim was to identify factors that predict the presence of PTLD to inform decision-making regarding adenotonsillectomy.
Methods: The electronic medical records at a quaternary children's hospital were queried over a 23-year period (2000-2023) for solid organ transplant patients that underwent tonsillectomy and/or adenoidectomy. Demographics, clinical presentation, and EBV serologies were analyzed to determine factors associated with presence of PTLD on final pathology.
Results: A total of 114 patients met inclusion criteria for analysis. Thirty-two of the 114 patients (28.1%) who underwent tonsillectomy and/or adenoidectomy had PTLD. Age at transplant, age at biopsy, sex, race, and type of organ transplanted were not found to be associated with development of PTLD. Patients with PTLD were more likely to have smaller tonsils, sore throat, fever, and tonsillar exudate; they were less likely to experience sleep disordered breathing. The immunosuppression agent used for induction and the number of maintenance immunosuppressive medications were not associated with the development of PTLD. Increased Epstein-Barr Virus (EBV) PCR copy number correlated to increased risk of developing PTLD (p < 0.003).
Conclusion: Tonsillar hypertrophy and sleep disordered breathing are not necessarily indicative of the presence of PTLD. Suspicion for adenotonsillar PTLD should be based on symptomatology, clinical exam, EBV serologies, and degree of EBV PCR positivity. Sore throat, fever, tonsillar exudates, and significant elevation in EBV PCR copy number are particularly concerning for PTLD.
Level of evidence: 3 Laryngoscope, 135:2182-2189, 2025.
Keywords: head and neck; lymphoproliferative disorder; palatine tonsil; pediatric; posttransplant; tonsillectomy.
© 2025 The American Laryngological, Rhinological and Otological Society, Inc.
References
BIBLIOGRAPHY
-
- Buell JF, Gross TG, Thomas MJ, et al. Malignancy in pediatric transplant recipients. Semin Pediatr Surg. 2006;15(3):179‐187. https://doi.org/10.1053/j.sempedsurg.2006.03.005.
-
- Roberts J, Powell J, Mather MW, Powell S, Brodlie M. A review of adenotonsillar hypertrophy and adenotonsillectomy in children after solid organ transplantation. Int J Pediatr Otorhinolaryngol. 2018;114:29‐35. https://doi.org/10.1016/j.ijporl.2018.08.020 [published Online First: 20180823].
-
- Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009;125(8):1747‐1754. https://doi.org/10.1002/ijc.24439.
-
- Garcia Arteaga JP, Cardozo MS, Pastore CS, Khouri M, Sommerfleck PA. Indication for tonsillectomy in pediatric patients with suspected post‐transplant lymphoproliferative disorder. Arch Argent Pediatr. 2023;121(2):e202202694. https://doi.org/10.5546/aap.2022-02694.eng [published Online First: 20221229].
-
- Akbas A, Tiede C, Lemound J, Maecker‐Kolhoff B, Kreipe H, Hussein K. Post‐transplant lymphoproliferative disorders with naso‐ and oropharyngeal manifestation. Transpl Int. 2015;28(11):1299‐1307. https://doi.org/10.1111/tri.12632 [published Online First: 20150730].
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
